Fifteen Years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and Observations from 2,359 Older Adults Spanning the Spectrum from Cognitive Normality to Alzheimer’s Disease

Author:

Fowler Christopher1,Rainey-Smith Stephanie R.2345,Bird Sabine23,Bomke Julia6,Bourgeat Pierrick6,Brown Belinda M.34,Burnham Samantha C.6,Bush Ashley I.1,Chadunow Carolyn1,Collins Steven1,Doecke James67,Doré Vincent68,Ellis Kathryn A.1910,Evered Lis11,Fazlollahi Amir6,Fripp Jurgen6,Gardener Samantha L.23,Gibson Simon6,Grenfell Robert6,Harrison Elise1,Head Richard6,Jin Liang1,Kamer Adrian1,Lamb Fiona8,Lautenschlager Nicola T.9,Laws Simon M.1213,Li Qiao-Xin1,Lim Lucy23,Lim Yen Ying114,Louey Andrea1,Macaulay S. Lance6,Mackintosh Lucy1,Martins Ralph N.2315,Maruff Paul16,Masters Colin L.1,McBride Simon6,Milicic Lidija12,Peretti Madeline12,Pertile Kelly1,Porter Tenielle1213,Radler Morgan1,Rembach Alan1,Robertson Joanne1,Rodrigues Mark23,Rowe Christopher C.83,Rumble Rebecca1,Salvado Olivier17,Savage Greg18,Silbert Brendan11,Soh Magdalene23,Sohrabi Hamid R.3415,Taddei Kevin23,Taddei Tania23,Thai Christine1,Trounson Brett1,Tyrrell Regan8,Vacher Michael6,Varghese Shiji1,Villemagne Victor L.819,Weinborn Michael235,Woodward Michael20,Xia Ying6,Ames David1921,

Affiliation:

1. The Florey Institute, The University of Melbourne, Parkville, VIC, Australia

2. Centre of Excellence for Alzheimer’s Disease Research and Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia

3. Australian Alzheimer’s Research Foundation (Ralph and Patricia Sarich Neuroscience Research Institute), Nedlands, WA, Australia

4. Centre for Healthy Ageing, Health Futures Institute, Murdoch University, Murdoch, WA, Australia

5. School of Psychological Science, University of Western Australia, Crawley, WA, Australia

6. Australian E-Health Research Centre, CSIRO Health & Biosecurity, Herston, QLD, Australia

7. Cooperative Research Council for Mental Health, Melbourne, VIC, Australia

8. Department of Molecular Imaging and Therapy, Austin Health, Heidelberg, VIC, Australia

9. University of Melbourne Academic Unit for Psychiatry of Old Age, Parkville, VIC, Australia

10. Melbourne School of Psychological Sciences, Melbourne, VIC, Australia

11. Department of Anaesthesia and Acute Pain Medicine, St Vincent’s Hospital Melbourne, Victoria Parade, Fitzroy, VIC, Australia

12. Collaborative Genomics and Translation Group, Centre for Precision Health, School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia

13. School of Pharmacy and Biomedical Sciences, Faculty of Health Sciences, Curtin Health Innovation Research Institute, Curtin University, Bentley, WA, Australia

14. Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, VIC, Australia

15. Department of Biomedical Sciences, Macquarie University, North Ryde, NSW, Australia

16. Cogstate Limited, Melbourne, VIC, Australia

17. CSIRO Data61, Brisbane, QLD, Australia

18. Department of Psychology, Macquarie University, Sydney, NSW, Australia

19. Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA

20. Department of Geriatric Medicine Austin Hospital, Heidelberg, VIC, Australia

21. National Ageing Research Institute (NARI), Parkville, VIC, Australia

Abstract

Background: The Australian Imaging, Biomarkers and Lifestyle (AIBL) Study commenced in 2006 as a prospective study of 1,112 individuals (768 cognitively normal (CN), 133 with mild cognitive impairment (MCI), and 211 with Alzheimer’s disease dementia (AD)) as an ‘Inception cohort’ who underwent detailed ssessments every 18 months. Over the past decade, an additional 1247 subjects have been added as an ‘Enrichment cohort’ (as of 10 April 2019). Objective: Here we provide an overview of these Inception and Enrichment cohorts of more than 8,500 person-years of investigation. Methods: Participants underwent reassessment every 18 months including comprehensive cognitive testing, neuroimaging (magnetic resonance imaging, MRI; positron emission tomography, PET), biofluid biomarkers and lifestyle evaluations. Results: AIBL has made major contributions to the understanding of the natural history of AD, with cognitive and biological definitions of its three major stages: preclinical, prodromal and clinical. Early deployment of Aβ-amyloid and tau molecular PET imaging and the development of more sensitive and specific blood tests have facilitated the assessment of genetic and environmental factors which affect age at onset and rates of progression. Conclusion: This fifteen-year study provides a large database of highly characterized individuals with longitudinal cognitive, imaging and lifestyle data and biofluid collections, to aid in the development of interventions to delay onset, prevent or treat AD. Harmonization with similar large longitudinal cohort studies is underway to further these aims.

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3